McKesson (NYSE:MCK) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of McKesson (NYSE:MCK) from a hold rating to a buy rating in a research report released on Saturday morning.

A number of other research analysts have also commented on MCK. William Blair started coverage on McKesson in a report on Tuesday. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. upped their price objective on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Weiss Ratings downgraded McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, UBS Group cut their target price on McKesson from $1,012.00 to $1,000.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $972.27.

McKesson Price Performance

Shares of NYSE MCK opened at $814.69 on Friday. The stock’s fifty day moving average price is $894.86 and its two-hundred day moving average price is $859.80. McKesson has a one year low of $637.00 and a one year high of $999.00. The firm has a market cap of $99.79 billion, a price-to-earnings ratio of 23.43, a P/E/G ratio of 1.18 and a beta of 0.35.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period in the prior year, the firm posted $8.03 EPS. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts anticipate that McKesson will post 39.02 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio is presently 9.43%.

Insider Buying and Selling

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 3,592 shares of company stock valued at $3,518,555. 0.08% of the stock is owned by insiders.

Institutional Trading of McKesson

Several institutional investors and hedge funds have recently modified their holdings of MCK. Brighton Jones LLC lifted its position in shares of McKesson by 46.3% during the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson during the 1st quarter worth $233,000. Sivia Capital Partners LLC lifted its position in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in shares of McKesson by 0.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock worth $42,958,000 after buying an additional 508 shares during the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in shares of McKesson during the 2nd quarter worth $166,000. 85.07% of the stock is currently owned by institutional investors.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.